LLS Launches Co-Pay Assistance Fund for Mantle Cell Lymphoma

The Leukemia and Lymphoma Society, the largest charity in the world dedicated to blood disorders, has announced a new co-pay assistance program fund.

The Leukemia and Lymphoma Society's Co-Pay Assistance Program provides direct financial assistance to patients living with a blood cancer to help them pay for insurance premiums and co-pay obligations.

Call

A new assistance program

The latest disease Co-Pay Assistance Program fund at the LLS has been established for qualified patients who have been diagnosed with mantle cell lymphoma (MCL).

The MCL co-pay program is available for patients who have health insurance, including Medicare and Medicaid, and who meet specific financial criteria.

Approved MCL patients might receive as much as $5,000 per year. Acceptance is provided on a first-come, first-served basis. It remains open for as long as funding is available.

Patients can apply for the program by calling toll-free (877) 557-2672 or by going online to www.lls.org/copay.

Call

More Articles

More Articles

This entry looks at Non Hodgkin's Lymphoma in the lungs, clinically known as pulmonary lymphoma, one of the subtypes of lymphoma. 'Lymphoma' is an...

In order to prevent developing any subtype of lymphoma, it would be helpful to know the causes of lymphoma. Unfortunately, in virtually every case...

BEAM chemotherapy is an acronym representing a small family of combination chemotherapy regimens that are used chiefly as salvage regimens in the...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

The Erythrocyte Sedimentation Rate (ESR - sometimes called sed rate or sedimentation rate) is a nonspecific screening test for various...

Blood counts can be used to identify disease and monitor patient health during cancer treatments. Though these tests cannot diagnose lymphoma on...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...

According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...

In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...

Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...

Since so many chemotherapy agents can affect a patient’s sex drive and fertility, thinking about these issues prior...